The antagonist of GRM5 could significantly induce a reduction in cell proliferation of laryngeal cancer RK33 and RK45 cells [20], and GRM5 overexpression promoted melanoma development in transgenic mice [21], indicating that GRM5 functions as an oncogene in laryngeal cancer and melanoma. The gene discussed is GRM5; the disease is melanoma.